Study Evaluating Fosfomycin/Tobramycin for Inhalation in Cystic Fibrosis Patients With Pseudomonas Aeruginosa Lung Infection
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
36 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Anchorage, Alaska, United States
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Tucson, Arizona, United States
- Facility name not stated
Little Rock, Arkansas, United States
- Facility name not stated
Palo Alto, California, United States
- Facility name not stated
Denver, Colorado, United States
- Facility name not stated
Hartford, Connecticut, United States
- Facility name not stated
New Haven, Connecticut, United States
- Facility name not stated
Washington D.C., District of Columbia, United States
- Facility name not stated
Orlando, Florida, United States
- Facility name not stated
Tampa, Florida, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Glenview, Illinois, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Boston, Massachusetts, United States
- Facility name not stated
Ann Arbor, Michigan, United States
- Facility name not stated
Detroit, Michigan, United States
- Facility name not stated
Las Vegas, Nevada, United States
- Facility name not stated
Albany, New York, United States
- Facility name not stated
Buffalo, New York, United States
- Facility name not stated
New Hyde Park, New York, United States
- Facility name not stated
New York, New York, United States
- Facility name not stated
Syracuse, New York, United States
- Facility name not stated
Chapel Hill, North Carolina, United States
- Facility name not stated
Cincinnati, Ohio, United States
- Facility name not stated
Cleveland, Ohio, United States
- Facility name not stated
Columbus, Ohio, United States
- Facility name not stated
Oklahoma City, Oklahoma, United States
- Facility name not stated
Hershey, Pennsylvania, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
Charleston, South Carolina, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
San Antonio, Texas, United States
- Facility name not stated
Portsmouth, Virginia, United States
- Facility name not stated
Richmond, Virginia, United States
- Facility name not stated
Tacoma, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2008
- Primary completion
- 28 Feb 2010
- Completion
- 31 Mar 2010
- Last update posted
- 27 Dec 2013
- Registered enrollment
- 120
- Registry id
- NCT00794586
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.